SLDB
Solid Biosciences LLC
7.50$
-6.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -96.6% | +7.8% | -1.6% | -10.8% | -39.0% | +220.5% | -100.0% | – | -100.0% | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -31.6% | +19.3% | +206.4% | -71.1% | +9.2% | -7.0% | +206.0% | -98.4% | +1.8% | -39.3% | +23.1% | +99.8% | -34.7% | -16.4% | -0.2% | -44.3% | +277.7% | -67.2% | +20.5% | -16.6% | -5.2% | -2.6% | +24.2% | -15.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -93.2% | +7.8% | -1.6% | -10.8% | -39.0% | +220.5% | -107.1% | – | -114.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +141.8% | +23.6% | -1.4% | +23.4% | +12.5% | -0.1% | +14.0% | +8.0% | +21.0% | +31.0% | -7.1% | +5.5% | +18.8% | -27.3% | -31.6% | +19.3% | -2.0% | -9.6% | +9.2% | -7.0% | +1.2% | +36.7% | +16.2% | -39.6% | +52.0% | +15.7% | -19.7% | -15.5% | -7.5% | +22.1% | +3.1% | +40.4% | +12.6% | +0.5% | +4.9% | +19.9% | -1.9% | +21.0% | -4.1% | – | |
| – | – | +225.5% | -39.0% | -6.2% | +4.5% | +25.8% | +13.4% | -2.5% | +3.4% | +52.1% | -23.8% | +29.2% | -24.0% | -0.3% | +5.3% | -6.2% | +8.6% | +7.0% | +12.5% | +5.6% | +1.0% | +2.0% | -6.8% | +4.0% | +6.9% | -2.9% | -3.6% | -10.1% | +6.2% | +17.3% | +4.2% | -5.7% | +16.2% | +0.1% | +1.5% | -0.9% | +22.5% | -0.9% | +17.5% | – | |
| – | +114.3% | +61.8% | -15.8% | +15.2% | +10.7% | +5.4% | +13.8% | +5.3% | +16.9% | +35.4% | -11.0% | +10.2% | +8.8% | -16.9% | -29.4% | +11.9% | +0.6% | -5.3% | +10.2% | -3.2% | +1.1% | +25.2% | +15.6% | -33.0% | +63.6% | -7.3% | -16.2% | -13.9% | -3.7% | +19.2% | +4.7% | +26.6% | +13.4% | -0.6% | +4.2% | +16.3% | +2.8% | +15.2% | +0.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +53.8% | -20.0% | -12.5% | -7.1% | – | – | – | +559.1% | +149.0% | +2,635.3% | -99.4% | -8.3% | -4.5% | +1,749.1% | -95.2% | -7.4% | -6.8% | -8.5% | -9.3% | -11.8% | +460.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -106.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | -107.7% | – | – | – | – | – | – | – | – | – | -93.8% | -535.3% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.